Idorsia's recently approved insomnia drug Quviviq hits the shelves

Idorsia, a Swiss pharmaceutical company that has its U.S. headquarters on the Main Line, has launched its first commercial product in the United States.

Quviviq was approved by the Food and Drug Administration in January as a treatment for adults with insomnia.